| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |